ENDONOVO THERAPEUTICS, INC. Common Stock Shares Outstanding

Quick Answer

ENDONOVO THERAPEUTICS, INC. reported Common Stock Shares Outstanding of 213.23 million shares for the year ending 2022.

  • ENDONOVO THERAPEUTICS, INC. showed an increase of +186.2% in Common Stock Shares Outstanding from 2021 to 2022.
  • This data is from ENDONOVO THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on April 17, 2023.
  • XBRL data for this metric is available from 2014 to 2022 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2014 to 2022), ENDONOVO THERAPEUTICS, INC.'s Common Stock Shares Outstanding has grown by 161.9%.
  • Historical annual values: Fiscal year 2022: 213.23 million shares | Fiscal year 2021: 74.50 million shares | Fiscal year 2020: 24.54 million shares | Fiscal year 2019: 1.19 million shares | Fiscal year 2018: 431,063 shares | Fiscal year 2017: 316.95 million shares | Fiscal year 2016: 134.34 million shares | Fiscal year 2016: 108.03 million shares | Fiscal year 2015: 104.80 million shares | Fiscal year 2015: 103.29 million shares | Fiscal year 2014: 81.43 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: